Data / Drug companies / Spi Pharma Inc.
Spi Pharma Inc.: 17 products in the FDA NDC directory, labeler code 67417
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Spi Pharma Inc. (labeler code 67417) lists 17 products in the FDA National Drug Code Directory. By type: 15 drugs for further processing, 2 bulk ingredients. Its main marketing category is drugs for further processing. The newest product started marketing on June 18, 2026.
The request: Watch Spi Pharma Inc. (FDA labeler code 67417): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 67417
- Products in commercial distribution
- 17
- Packages
- 17
- Finished drugs by generic name
- 0
- Prescription products
- 0
- Over the counter products
- 0
- Started marketing in the last 12 months
- 3
- Earliest marketing start
- May 5, 2015
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Drugs for further processing | 17 | 100% |
Products by type
| Type | Products | Share |
|---|---|---|
| Drugs for further processing | 15 | 88.2% |
| Bulk ingredients | 2 | 11.8% |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Gel | 10 | 58.8% |
| Powder | 3 | 17.6% |
| Paste | 3 | 17.6% |
| Granule | 1 | 5.9% |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Aluminium hydroxide | 67417-250 | Gel | Drugs for further processing | June 18, 2026 |
| Aluminum hydroxide magnesium hydroxide | 67417-249 | Powder | Drugs for further processing | January 14, 2026 |
| Magnesium hydroxide | 67417-248 | Paste | Drugs for further processing | January 14, 2026 |
| Aluminum hydroxide gel | 67417-247 | Gel | Drugs for further processing | September 3, 2025 |
| Aluminum phosphate | 67417-246 | Gel | Drugs for further processing | September 3, 2025 |
| Magnesium hydroxide | 67417-243 | Powder | Drugs for further processing | November 2, 2021 |
| Aluminum hydroxid wet gel | 67417-242 | Gel | Drugs for further processing | January 29, 2020 |
| Calcium carbonate dc | 67417-241 | Granule | Drugs for further processing | January 28, 2020 |
| Aluminium hydroxide | 67417-234 | Gel | Drugs for further processing | January 28, 2020 |
| Aluminium phosphate | 67417-233 | Gel | Drugs for further processing | January 27, 2020 |
| Magnesium hydroxide | 67417-222 | Paste | Drugs for further processing | January 27, 2020 |
| Aluminum hydroxide gel | 67417-240 | Gel | Drugs for further processing | July 4, 2018 |
| Aluminum hydroxide magnesium hydroxide | 67417-239 | Powder | Drugs for further processing | July 2, 2018 |
| Aluminium hydroxide | 67417-235 | Gel | Drugs for further processing | May 6, 2015 |
| Magnesium hydroxide | 67417-223 | Paste | Drugs for further processing | May 6, 2015 |
| Aluminium hydroxide | 67417-220 | Gel | Drugs for further processing | May 6, 2015 |
| Aluminium hydroxide | 67417-221 | Gel | Drugs for further processing | May 5, 2015 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.